34 studies found for:    ALZHEIMER DISEASE 12
Show Display Options
Rank Status Study
1 Completed A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal
2 Active, not recruiting Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ANAVEX2-73 Oral;   Drug: ANAVEX2-73 Intravenous
3 Completed The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Donepezil;   Drug: Placebo to match Aricept
4 Enrolling by invitation 12-Month Open-Label Extension Study of RVT-101 in Subjects With Alzheimer's Disease: MINDSET Extension
Condition: Alzheimer's Disease
Intervention: Drug: RVT-101 35 mg tablets
5 Completed EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
6 Completed Escitalopram for the Treatment of Depression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: escitalopram;   Drug: Placebo
7 Withdrawn Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
Condition: Severe Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride (Aricept)
8 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
9 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
10 Completed Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: AZD3480;   Drug: Donepezil
11 Completed Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: PBT2
12 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
13 Recruiting A Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
14 Recruiting Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
15 Recruiting Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ORM-12741;   Drug: Placebo
16 Completed Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
17 Recruiting Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo
Condition: Alzheimer Disease
Interventions: Drug: BI 409306;   Drug: Placebo
18 Not yet recruiting BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Condition: Alzheimer Disease
Interventions: Drug: BI 425809 dose 1;   Drug: BI 425809 dose 2;   Drug: BI 425809 dose 3;   Drug: BI 425809 dose 4;   Drug: Placebo
19 Recruiting BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Condition: Alzheimer Disease
Interventions: Drug: Placebo;   Drug: BI 409306;   Drug: Donepezil
20 Completed Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.
Condition: Alzheimer Disease
Intervention: Drug: AVE1625

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years